Page last updated: 2024-12-06

pirozadil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pirozadil: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68711
CHEMBL ID2106888
CHEBI ID135818
SCHEMBL ID310159
MeSH IDM0064709

Synonyms (34)

Synonym
pirozadil
pemix
722d
2,6-pyridinedimethanol bis(3,4,5-trimethoxybenzoate)
brn 1521700
2,6-pyridinediyldimethylene bis(3,4,5-trimethoxybenzoate)
einecs 258-978-1
benzoic acid, 3,4,5-trimethoxy-, 2,6-pyridinediylbis(methylene) ester
2,6-pyridinediyldimethylene-bis(3,4,5-trimethoxybenzoate)
pirozadilum [inn-latin]
2,6-pyridinediylbis(methylene) 3,4,5-trimethoxybenzoate
pirozadil [inn]
CHEBI:135818
[6-[(3,4,5-trimethoxybenzoyl)oxymethyl]pyridin-2-yl]methyl 3,4,5-trimethoxybenzoate
54110-25-7
CHEMBL2106888
pirozadilum
unii-54978vna4t
54978vna4t ,
SCHEMBL310159
pirozadil [mi]
pirozadil [who-dd]
pirozadil [mart.]
DTXSID70202458
CS-0018132
HY-100144
pemix;pirozadilum
BCP30377
Q27261197
F79833
MS-29762
EX-A3227
AKOS037515639
Z2681891397

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
trihydroxybenzoic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.51 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]